Juvenescence is a life sciences company developing therapies to modify aging and increase healthy human lifespan.
Juvenescence has raised €67M across 1 funding round from 2 investors, most recently a Series B round in May 2025. Based in Ramsey, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-05-26 | Series B | €67M |
| Existing investors,M42 |
| View deal → |
